Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways

Trai Ming Yeh, Shu Hsiang Liu, Kao Chang Lin, Chieh Kuo, Shu Yun Kuo, Tzuu Yuan Huang, Yong Ren Yen, Rong Kun Wen, Lien Cheng Chen, Tsai Feng Fu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Dengue virus (DV) infections cause mild dengue fever (DF) or severe life-threatening dengue hemorrhagic fever (DHF). The mechanisms that cause hemorrhage in DV infections remain poorly understood. Thrombomodulin (TM) is a glycoprotein expressed on the surface of vascular endothelial cells that plays an important role in the thrombin-mediated activation of protein C. Prior studies have shown that the serum levels of soluble TM (sTM) and macrophage migration inhibitory factor (MIF) are significantly increased in DHF patients compared to levels in DF patients or normal controls. In this study, we investigated how MIF and sTM concentrations are enhanced in the plasma of DHF patients and the potential effect of MIF on coagulation through its influence on two factors: thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1) in endothelial cells and monocytes. Recombinant human macrophage migration inhibitory factor (rMIF) was used to treat monocytic THP-1 cells and endothelial HMEC-1 cells or primary HUVEC cells. The subsequent expression of TM and ICAM-1 was assessed by immunofluorescent staining and flow cytometry analysis. Additionally, the co-incubation of THP-1 cells with various cell signaling pathway inhibitors was used to determine the pathways through which MIF mediated its effect. The data provided evidence that severe DV infections induce MIF expression, which in turn stimulates monocytes or endothelial cells to express TM and ICAM-1 via the Erk, JNK MAPK and the PI3K signaling pathways, supporting the idea that MIF may play an important role as a regulator of coagulation.

Original languageEnglish
Article numbere55018
JournalPloS one
Volume8
Issue number1
DOIs
Publication statusPublished - 2013 Jan 28

Fingerprint

Macrophage Migration-Inhibitory Factors
Thrombomodulin
Dengue virus
Dengue Virus
phosphatidylinositol 3-kinase
Severe Dengue
Intercellular Adhesion Molecule-1
Phosphatidylinositol 3-Kinases
Viruses
adhesion
Endothelial cells
Virus Diseases
Endothelial Cells
endothelial cells
dengue
Dengue
Coagulation
coagulation
monocytes
cells

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Yeh, Trai Ming ; Liu, Shu Hsiang ; Lin, Kao Chang ; Kuo, Chieh ; Kuo, Shu Yun ; Huang, Tzuu Yuan ; Yen, Yong Ren ; Wen, Rong Kun ; Chen, Lien Cheng ; Fu, Tsai Feng. / Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways. In: PloS one. 2013 ; Vol. 8, No. 1.
@article{56399fe207c04c529421182dc4c94615,
title = "Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways",
abstract = "Dengue virus (DV) infections cause mild dengue fever (DF) or severe life-threatening dengue hemorrhagic fever (DHF). The mechanisms that cause hemorrhage in DV infections remain poorly understood. Thrombomodulin (TM) is a glycoprotein expressed on the surface of vascular endothelial cells that plays an important role in the thrombin-mediated activation of protein C. Prior studies have shown that the serum levels of soluble TM (sTM) and macrophage migration inhibitory factor (MIF) are significantly increased in DHF patients compared to levels in DF patients or normal controls. In this study, we investigated how MIF and sTM concentrations are enhanced in the plasma of DHF patients and the potential effect of MIF on coagulation through its influence on two factors: thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1) in endothelial cells and monocytes. Recombinant human macrophage migration inhibitory factor (rMIF) was used to treat monocytic THP-1 cells and endothelial HMEC-1 cells or primary HUVEC cells. The subsequent expression of TM and ICAM-1 was assessed by immunofluorescent staining and flow cytometry analysis. Additionally, the co-incubation of THP-1 cells with various cell signaling pathway inhibitors was used to determine the pathways through which MIF mediated its effect. The data provided evidence that severe DV infections induce MIF expression, which in turn stimulates monocytes or endothelial cells to express TM and ICAM-1 via the Erk, JNK MAPK and the PI3K signaling pathways, supporting the idea that MIF may play an important role as a regulator of coagulation.",
author = "Yeh, {Trai Ming} and Liu, {Shu Hsiang} and Lin, {Kao Chang} and Chieh Kuo and Kuo, {Shu Yun} and Huang, {Tzuu Yuan} and Yen, {Yong Ren} and Wen, {Rong Kun} and Chen, {Lien Cheng} and Fu, {Tsai Feng}",
year = "2013",
month = "1",
day = "28",
doi = "10.1371/journal.pone.0055018",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways. / Yeh, Trai Ming; Liu, Shu Hsiang; Lin, Kao Chang; Kuo, Chieh; Kuo, Shu Yun; Huang, Tzuu Yuan; Yen, Yong Ren; Wen, Rong Kun; Chen, Lien Cheng; Fu, Tsai Feng.

In: PloS one, Vol. 8, No. 1, e55018, 28.01.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways

AU - Yeh, Trai Ming

AU - Liu, Shu Hsiang

AU - Lin, Kao Chang

AU - Kuo, Chieh

AU - Kuo, Shu Yun

AU - Huang, Tzuu Yuan

AU - Yen, Yong Ren

AU - Wen, Rong Kun

AU - Chen, Lien Cheng

AU - Fu, Tsai Feng

PY - 2013/1/28

Y1 - 2013/1/28

N2 - Dengue virus (DV) infections cause mild dengue fever (DF) or severe life-threatening dengue hemorrhagic fever (DHF). The mechanisms that cause hemorrhage in DV infections remain poorly understood. Thrombomodulin (TM) is a glycoprotein expressed on the surface of vascular endothelial cells that plays an important role in the thrombin-mediated activation of protein C. Prior studies have shown that the serum levels of soluble TM (sTM) and macrophage migration inhibitory factor (MIF) are significantly increased in DHF patients compared to levels in DF patients or normal controls. In this study, we investigated how MIF and sTM concentrations are enhanced in the plasma of DHF patients and the potential effect of MIF on coagulation through its influence on two factors: thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1) in endothelial cells and monocytes. Recombinant human macrophage migration inhibitory factor (rMIF) was used to treat monocytic THP-1 cells and endothelial HMEC-1 cells or primary HUVEC cells. The subsequent expression of TM and ICAM-1 was assessed by immunofluorescent staining and flow cytometry analysis. Additionally, the co-incubation of THP-1 cells with various cell signaling pathway inhibitors was used to determine the pathways through which MIF mediated its effect. The data provided evidence that severe DV infections induce MIF expression, which in turn stimulates monocytes or endothelial cells to express TM and ICAM-1 via the Erk, JNK MAPK and the PI3K signaling pathways, supporting the idea that MIF may play an important role as a regulator of coagulation.

AB - Dengue virus (DV) infections cause mild dengue fever (DF) or severe life-threatening dengue hemorrhagic fever (DHF). The mechanisms that cause hemorrhage in DV infections remain poorly understood. Thrombomodulin (TM) is a glycoprotein expressed on the surface of vascular endothelial cells that plays an important role in the thrombin-mediated activation of protein C. Prior studies have shown that the serum levels of soluble TM (sTM) and macrophage migration inhibitory factor (MIF) are significantly increased in DHF patients compared to levels in DF patients or normal controls. In this study, we investigated how MIF and sTM concentrations are enhanced in the plasma of DHF patients and the potential effect of MIF on coagulation through its influence on two factors: thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1) in endothelial cells and monocytes. Recombinant human macrophage migration inhibitory factor (rMIF) was used to treat monocytic THP-1 cells and endothelial HMEC-1 cells or primary HUVEC cells. The subsequent expression of TM and ICAM-1 was assessed by immunofluorescent staining and flow cytometry analysis. Additionally, the co-incubation of THP-1 cells with various cell signaling pathway inhibitors was used to determine the pathways through which MIF mediated its effect. The data provided evidence that severe DV infections induce MIF expression, which in turn stimulates monocytes or endothelial cells to express TM and ICAM-1 via the Erk, JNK MAPK and the PI3K signaling pathways, supporting the idea that MIF may play an important role as a regulator of coagulation.

UR - http://www.scopus.com/inward/record.url?scp=84873809189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873809189&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0055018

DO - 10.1371/journal.pone.0055018

M3 - Article

C2 - 23383040

AN - SCOPUS:84873809189

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e55018

ER -